Acute Lymphoblastic Leukemia
Acute lymphoblastic leukemia remission is likely when lymphangiogenesis factor is absent
Published in Cancer Weekly, September 12th, 2006
Scientists in Poland conducted a study "to investigate the immunocytochemical expression of vascular endothelial growth factor C (VEGF-C) and its receptors (VEGFR-2 and VEGFR-3) in childhood ALL blasts and to determine the possible role of this complex in the pathogenesis and prognosis of ALL. Bone marrow samples were taken from 120 children diagnosed with ALL."
"An indirect immunocytochemical procedure was performed with the use of monoclonal mouse anti-human antibodies against VEGF-C, VEGFR-2 and VEGFR-3 (diluted 1:100). The immunocytochemical expression...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2006-09-12)
More Articles from Cancer Weekly
- Breast Cancer
Breast cancer outcome associated with status of p53 and MDM2 SNP309 - Crohn Colitis
Crohn colitis patients requiring surgery linked to higher risk of dysplasia and adenocarcinoma - End-of-Life Issues
End-of-life cancer patients' spiritual needs measured by Spiritual Needs Inventory - Endometrial Cancer
Endometrioid endometrial carcinoma's loss of PTEN expression linked to cyclin D1 overexpression - Lung Cancer
Lung cancer patients could safely receive higher doses of radiation than traditionally administered - Acute Lymphoblastic Leukemia
Hana initiates Marqibo phase II trial in relapsed or refractory acute lymphoblastic leukemia - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
